Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)

被引：0
|
作者：
Anita Kort
Selvi Durmus
Rolf W. Sparidans
Els Wagenaar
Jos H. Beijnen
Alfred H. Schinkel
机构：
[1] The Netherlands Cancer Institute,Division of Molecular Oncology
[2] Utrecht University,Division of Pharmacoepidemiology & Clinical Pharmacology Department of Pharmaceutical Sciences, Faculty of Science
[3] The Netherlands Cancer Institute/ Slotervaart Hospital,Department of Pharmacy & Pharmacology
[4] The Netherlands Cancer Institute,Department of Clinical Pharmacology
来源：
Pharmaceutical Research | 2015年 / 32卷
关键词：
ABCB1; ABCG2; brain accumulation; regorafenib; testis accumulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2205 / 2216
页数：11
相关论文
共 50 条
  • [31] Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar
    Tang, Seng Chuan
    Nguyen, Luan N.
    Sparidans, Rolf W.
    Wagenaar, Els
    Beijnen, Jos H.
    Schinkel, Alfred H.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (06) : 1484 - 1494
  • [32] Localization of P-glycoprotein (ABCB1, P-gp) in brain cellular and subcellular compartments
    Bendayan, R
    Ronaldson, PT
    Lee, G
    Gingras, D
    Bendayan, M
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S58 - S58
  • [33] Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the p-Glycoprotein (ABCB1) Modulator Tariquidar
    Kuehnle, Matthias
    Egger, Michael
    Mueller, Christine
    Mahringer, Anne
    Bernhardt, Guenther
    Fricker, Gert
    Koenig, Burkhard
    Buschauer, Armin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (04) : 1190 - 1197
  • [34] Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening
    Tournier, Nicolas
    Valette, Heric
    Peyronneau, Marie-Anne
    Saba, Wadad
    Goutal, Sebastien
    Kuhnast, Bertrand
    Dolle, Frederic
    Scherrmann, Jean-Michel
    Cisternino, Salvatore
    Bottlaender, Michel
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (03) : 415 - 423
  • [35] In silico analysis of nsSNPs in ABCB1 gene affecting breast cancer associated protein P-glycoprotein (P-gp)
    Chakraborty, Rajkumar
    Gupta, Himani
    Rahman, Razia
    Hasija, Yasha
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 77 : 430 - 441
  • [36] Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib (PLX4032)
    Mittapalli, Rajendar K.
    Vaidhyanathan, Shruthi
    Sane, Ramola
    Elmquist, William F.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (01): : 33 - 40
  • [37] P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Localize in the Microvessels Forming the Blood-Tumor Barrier in Ependymomas
    Ginguene, Carole
    Champier, Jacques
    Maallem, Said
    Strazielle, Nathalie
    Jouvet, Anne
    Fevre-Montange, Michelle
    Ghersi-Egea, Jean-Francois
    [J]. BRAIN PATHOLOGY, 2010, 20 (05) : 926 - 935
  • [38] Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice
    Agarwal, Sagar
    Uchida, Yasuo
    Mittapalli, Rajendar K.
    Sane, Ramola
    Terasaki, Tetsuya
    Elmquist, William F.
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1164 - 1169
  • [39] The "Specific" P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)
    Kannan, Pavitra
    Telu, Sanjay
    Shukla, Suneet
    Ambudkar, Suresh V.
    Pike, Victor W.
    Halldin, Christer
    Gottesman, Michael M.
    Innis, Robert B.
    Hall, Matthew D.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2011, 2 (02): : 82 - 89
  • [40] Correlation between expression of breast cancer resistance protein (BCRP) and that of P-glycoprotein (P-GP) in hepatocellular carcinoma (HCC).
    Fukuzawa, Y
    [J]. HEPATOLOGY, 2002, 36 (04) : 691A - 691A
12345